Faecal microbiota composition associates with abdominal pain in the general population.
Faecal microbiota composition associates with abdominal pain in the general population.
复制标题
DOI:
10.1136/gutjnl-2017-314792
复制
发表时间:
2018-04
期刊:
影响因子:
24.5
通讯作者:
D'Amato M
中科院分区:
文献类型:
--
作者:
Hadizadeh F;Bonfiglio F;Belheouane M;Vallier M;Sauer S;Bang C;Bujanda L;Andreasson A;Agreus L;Engstrand L;Talley NJ;Rafter J;Baines JF;Walter S;Franke A;D'Amato M
We read with great interest the recent communication by Simrén et al, 1 reporting a correlation between visceral hypersensitivity and GI symptom severity in functional GI disorders (FGID). Previously, it has been shown that visceral hypersensitivity can be modulated or even induced in animal models, by altering the composition of their gut microbiota with antibiotics or faecal transplantation from IBS donors. 2 3 Hence, while a direct link between gut microbiota composition and visceral pain may need to be conclusively established, this holds great potential for translational exploitation in the treatment of IBS and other FGID. Thus far, the potential association between microbiota and abdominal pain in humans has only been investigated in one study that included 15 individuals. 4 For this purpose, we studied 159 individuals (average age 59.1, 39.6% men) from the Swedish Population-based Colonoscopy (PopCol) cohort, previously described and with faecal microbiota 16S sequencing data and daily recordings of abdominal pain (number of episodes, duration and intensity) collected over the same period (7.41±7.91 days). 5–7 Among these, 52 individuals (assigned to the case group) reported at least one episode of light, moderate or intense pain (respective scores 1, 2 and 3), while the other 107 (controls) never reported pain. On average, those with pain experienced it 0.30 times per day (range 0.07–1.57), for 2.46 hours each time (range 0.37–9) and on a light-moderate intensity level of 1.39 per episode (range 1–2.1). When compared, both at the level of genus and species-level operational taxonomic units (OTU), β-diversity measures of faecal microbiota from cases and controls significantly differed (figure 1). In addition, significant correlations with microbiota β-diversity were detected for pain indices of frequency, duration and intensity (figure 1). Classifying individuals according to their microbiota profiles clustered into enterotypes(http://enterotyping. embl. de) resulted in three groups, respectively, enriched for unclassified Ruminococcaceae, Prevotella and Bacteroides. As shown in figure 2, a χ2 analysis revealed their distribution to be significantly different in cases and controls (p= 0.039), and the Prevotella-predominant enterotype was underrepresented in the pain group (21% vs 41% in controls). When taxa previously associated with abdominal symptoms in animal models and clinical studies (Bacteroides, unclassified Ruminococcaceae, Butyricicoccus, Prevotella, Faecalibacterium, Streptococcus, Bifidobacterium, Blautia, Akkermansia, Lactobacillus, Alistipes and Enterobacter) were compared with a Wilcoxon rank-sum test for their
登录
查看更多内容
影响因子:
3.5
作者:
Aguilera, M.;Vergara, P.;Martinez, V.
通讯作者:
Martinez, V.
影响因子:
29.4
作者:
Tap, Julien;Derrien, Muriel;Simren, Magnus
通讯作者:
Simren, Magnus
DOI:
10.1097/meg.0000000000000024
发表时间:
2014-03-01
影响因子:
2.1
作者:
Kjellstrom, Lars;Molinder, Herdis;Andreasson, Anna
通讯作者:
Andreasson, Anna
影响因子:
24.5
作者:
Simren, Magnus;Toernblom, Hans;Whitehead, William E.
通讯作者:
Whitehead, William E.
影响因子:
3.5
作者:
Crouzet, L.;Gaultier, E.;Bernalier-Donadille, A.
通讯作者:
Bernalier-Donadille, A.